The management of psoriasis comprises a variety of local and systemic therapies, involving phototherapy, retinoids, corticosteroids, vitamin D3 analogues, immunosuppressants, and recently emerged biologics targeting inflammatory factors, especially IL-17 (Kim and Krueger, 2017). The gene discussed is IL17A; the disease is psoriasis.